DOI: 10.1128/mSphere.00925-19
Article Information
PubMed
Published By
History
- Received December 9, 2019
- Accepted January 23, 2020
- Published online February 5, 2020.
Copyright & Usage
Copyright © 2020 Uddén et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers
- Drusilla L. Burns, Editor, U.S. Food and Drug Administration
Author Information
- Fabian Uddéna,
- Jonas Ahla,b,
- Nils Littorina,
- Kristoffer Strålinc,
- Simon Athlind and
- Kristian Riesbecka
- aClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden
- bInfectious Diseases, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden
- cUnit of Infectious Diseases, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
- dDepartment of Infectious Diseases, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
- Address correspondence to Kristian Riesbeck, kristian.riesbeck{at}med.lu.se.
Citation Uddén F, Ahl J, Littorin N, Strålin K, Athlin S, Riesbeck K. 2020. A nonfunctional opsonic antibody response frequently occurs after pneumococcal pneumonia and is associated with invasive disease. mSphere 5:e00925-19. https://doi.org/10.1128/mSphere.00925-19.
